Targeting EIF4A1 is effective against human intrahepatic cholangiocarcinoma

Background & aims: Intrahepatic cholangiocarcinoma (iCCA) is the second most frequent primary liver tumor, characterized by clinical aggressiveness, dismal outcome, and limited therapeutic options. Thus, innovative treatments are urgently required to improve the prognosis of patients with iCCA....

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Wunan Mi, Antonio Cigliano, Grazia Galleri, Isabella Gigante, Sara Martina Steinmann, Ezgi Cibali, Marina Serra, Giovanni Mario Pes, Denise Schloesser, Elena Pizzuto, Heiko Siegmund, Claudia Fischer, Anna Saborowski, Gianluigi Giannelli, Matthias Evert, Luc Johannes Wilhelmus van der Laan, Monique Maria Andrea Verstegen, Diego Francesco Calvisi
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2025-07-01
Cyfres:	JHEP Reports
Pynciau:	Biliary tumors EIF4A1 Zotatifin Bcl-xl
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S258955592500093X
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!